BioNTech launches containerised vaccine manufacturing facility

News-in-print by WCN Editorial

German company Biopharmaceutical New Technologies (BioNTech) has announced a containerised, turnkey and scalable production plant for mRNA-based vaccine production.

Do you want to read the full article?

Register to continue reading

By registering you will have:

  • Access to all Premium content
  • Discount on selected events
  • Full access to the entire digital archive
  • 10x per year Digital Magazine

SUBSCRIBE or, if you are already a member Log In

 

Having problems logging in? Call +31(0)10 280 1000 or send an email to customerdesk@worldcargonews.com.
Container Industry News Pharma

Related articles

ACES high for Morris Kayitare

 News

Morris Kayitare has been appointed General Manager for the African Centre of Excellence for Sustainable Cooling and Cold Chain (ACES)

UPS acquires Italian pharma logistics specialist

 News

The acquisition of Bomi will add more than 350 temperature-controlled facilities (391,000 m2) in 14 countries and nearly 3,000 staff to the UPS Healthcare network in Europe and Latin America; SEKO Logistics acquires Pixior